glp 1 should i take it GLP-1 has changed the conversation around weight loss—but it's important to understand what can and cannot do. It's not the right choice for everyone, and it's not a replacement for healthy Part 1 of a 3-Part
Description
Tirzepatide versus semaglutide In the direct head-to-head comparison, the 1-year risk of the primary endpoint including all-cause mortality was 1.3% (95% CI 1.2% to 1.5%) for tirzepatide and 1.3% (95% CI 1.2% to 1.5%) for semaglutide, resulting in a risk difference of 0.0% (95% CI 0.2% to 0.2%) and an HR of 1.06 (95% CI 0.95 to 1.18) (Fig
The review included seven studies and 12,442 patients
This is simply because Ozempic drug trials focused on how it impacted blood sugar (like metformin does), while Wegovy drug trials focused on how it impacted weight
Snapin Mediates Incretin Action and Augments Glucose-dependent Insulin Secretion
Theres also encouraging news for women in menopause
Learn more about medical weight management at Inspira
